PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Nephrology, Department of Medicine, Stanford University, Palo Alto, California.\', \'Ascend Clinical Laboratory, Redwood City, California.\', \'Department of Pathology, Stanford University, Palo Alto, California.\', \'US Renal Care, Plano, Texas.\', \'Division of Infectious Diseases & Geographic Medicine, Department of Medicine, Stanford University, Palo Alto, California.\', \'Department of Epidemiology and Population Health, Stanford University, Palo Alto, California.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1001/jamanetworkopen.2021.16572
?:hasPublicationType
?:journal
  • JAMA network open
is ?:pmid of
?:pmid
?:pmid
  • 34251441
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all